RGD Reference Report - Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease.

Authors: Ehrmann J, JR  Kolek, A  Kod'ousek, R  Zapletalova, J  Lisova, S  Murray, PG  Drabek, J  Kolar, Z 
Citation: Ehrmann J Jr, etal., Virchows Arch. 2003 May;442(5):453-61. Epub 2003 Apr 16.
RGD ID: 1579994
Pubmed: PMID:12698366   (View Abstract at PubMed)
DOI: DOI:10.1007/s00428-003-0794-2   (Journal Full-text)

Mechanisms leading to morphological changes of the small intestine during coeliac disease (CD) are not yet completely recognized; however, two main processes have been suggested recently: remodeling of mucosa by matrix metalloproteinases, and mucosal atrophy by apoptosis. The aim of this study was analysis of the expression of proteins regulating apoptosis in the small intestine of children with active CD (ACD) and potential CD (PCD). Jejunal biopsies of 43 children with PCD and untreated ACD and 21 control samples were analyzed by means of standard indirect immunohistochemical technique for Fas, Fas ligand (Fas-L), tissue transglutaminase (tTG), Bcl-2, and glutathione S-transferase (GST) expression. We found significantly lower numbers of Fas-expressing enterocytes in the ACD patients than in PCD patients and controls. Similarly, the number of Fas-positive mucosal lymphocytes was decreased in ACD when compared with PCD. The number of Fas-L- and tTG-expressing enterocytes and mucosal lymphocytes was higher in both PCD and ACD. On the other hand, the number of Bcl-2-positive mucosal lymphocytes in PCD as well as ACD was significantly lower. The expression of tTG in extracellular matrix was significantly higher in PCD and ACD when compared with controls. Our results showed that Fas and/or Fas-L, Bcl-2, and tTG may be involved in apoptotic pathways leading to mucosal atrophy in children with CD. tTG changes are in agreement with the presumed role of this protein in the pathogenesis of CD.

Objects referenced in this article
Gene TGM2 transglutaminase 2 Homo sapiens
Gene Tgm2 transglutaminase 2, C polypeptide Mus musculus
Gene Tgm2 transglutaminase 2 Rattus norvegicus

Additional Information